Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03020576 · ClinicalTrials.gov registry record · NA

Robotic and Conventional Hand Therapy After Stroke

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
31
Enrollment target

NCT03020576 is a NA study that has completed, run by Columbia University. The registered enrollment target is 31 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03020576, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

Weakness is a major cause of disability in stroke survivors. Rehabilitation techniques are often not effective in restoring full function of the upper limb. Specifically, many individuals remain with weakness in the hand, preventing its return to full use. Robotic therapies have been developed as exercise tools for stroke survivors. Devices, such as the InMotion2, have been shown to be useful in restoring some motor function in the upper limb. However, most existing devices designed to be used with the upper limb have primarily been developed to treat the shoulder, elbow and wrist. They have not specifically addressed hand function. Tyromotion, Inc. has developed the Amadeo, which is primarily intended to provide rehabilitation for patients with neurological or orthopedic deficits in hand function. Initial clinical testing has demonstrated the practicality of using this device in a population of stroke survivors, although further research is needed to better understand the usefulness of the Amadeo device as compared with conventional rehabilitation methods. The purpose of this study was to compare results of training with the Amadeo device or training with conventional therapies. A total of 28 subjects from two separate sites participated in the study and underwent baseline testing of upper limb motor and sensory performance and function. Subjects were then assigned to one of two treatment groups with a 50:50 chance of being in either group. One group underwent training with the Amadeo device and the other group underwent training with conventional therapy. All training sessions were 60 minutes in duration, three days/week for eight weeks (24 total sessions). Subjects were reassessed on completion of the training program.

Interventions

  • OTHER Conventional Therapy
  • DEVICE Amadeo Hand Robot Device

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2011-04
Est. Completion 2016-03
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT03020576

The ClinicalTrials.gov registry entry for NCT03020576 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Conventional Therapy is the first listed.

NCT03020576 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03020576 about?

NCT03020576 is a clinical study titled "Robotic and Conventional Hand Therapy After Stroke". Weakness is a major cause of disability in stroke survivors. Rehabilitation techniques are often not effective in restoring full function of the upper limb. Specifically, many individuals remain with weakness in the hand, preventing its return to full use. Robotic therapies have been developed as e...

What is the current status of trial NCT03020576?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2011-04. Estimated completion is 2016-03.

What interventions are being tested in trial NCT03020576?

The interventions under investigation include: Conventional Therapy (OTHER), Amadeo Hand Robot Device (DEVICE).

Who is sponsoring clinical trial NCT03020576?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.